With "anti-vaxxers" dominating the headlines, Biss's new book is a thoughtful examination of how people feel about vaccines.
The biologist-turned-atheist campaigner is sampled on the band's forthcoming Endless Forms Most Beautiful.
It's time to appreciate space dust.
In mice, young blood can rejuvinate the arteries and even neurones of the old. But humans may be wary.
When more money in Britain is spent on researching cures for baldness than for malaria, then there's a problem.
The drug has been proven as a reliever of suicidal thoughts. With some doctors reluctant to prescribe SSRIs, it could provide the answer.
Osteoporosis gets less attention than the "big, ugly stepsisters' -- yet roughly three million in the UK are affected.
From eyecare to creating the coldest thing in the universe, lasers show science at its most illuminating.
Stephen Hawking received his "death sentence" more than 50 years ago. The Astronomer Royal pays tribute to him.
Want to understand your genes? Call your parents.
What should you do to stay happy and healthy this Christmas? You’ll like the first piece of advice: if you want to relax, you could try eating a big meal.
The basic chemistry of hair dyes has changed little over the last century, but what do we know about the risks of colouring our hair, and why do we do it?
Our planet has hidden life-protection systems that continue to surprise us.
Recent analysis of a bacterium that killed a First World War soldier showed that this bug was resistant to attacks by penicillin and erythromycin, even before we had discovered either of these antibiotic drugs.
Michael Brooks’s Science Column.
Michael Brooks’s Science Column.
Ettore Majorana was an Italian physicist, the best of his generation, who disappeared in mysterious circumstances in 1938.
A new report suggests that women are lost to a potential career in engineering at the age of 16, when A-level and vocational subject choices are made – More needs to be done to challenge society’s clichéd attitudes and expectations of “masculine” and “feminine” career paths.
A growing community of scientists, philosophers and tech billionaires believe we need to start thinking seriously about the threat of human extinction.
Nature Communications will be the first Nature-branded open access-only journal - a huge step in the right direction for the progression of scientific communication.
Chinese researchers have recently reported a case of a woman found to have no cerebellum, a part of the brain that usually contains half of its neurons.
Homeopaths can now get their "medicine" accredited by an official regulatory body, to the dismay of critics.
Restrictive copyright licenses and expensive submission fees have led to a significant number of scientists to criticise Science Advances, a new journal due to launch next year, for failing to live up to its open access principles.
A US particle physics and accelerator laboratory recently announced an exciting new project to answer the question of whether our universe is a giant two-dimensional hologram.
They’re less likely to divorce and they do an extra hour of housework each week.
As students across the country receive their GCSE results, many will be realising that there is no escape from comparisons with their peers thanks to the growth of social media. But does it represent the truth?
A recent study is the first study to demonstrate that 'virtual humans' could help patients overcome psychological barriers to honesty in medical interviews especially for sensitive, personal and highly stigmatized topics - these findings could prevent potentially serious consequences for the patient’s health, such as incorrect diagnosis.
When Kim Goodsell discovered that she had two extremely rare genetic diseases, she taught herself genetics to help find out why. Ed Yong tells her story.
Alice Robb talks to sociologist Sarah Diefendorf about what it’s like to be a secular woman at a virginity support group for religious men.
In light of the news that new cancer medications won’t be made available to NHS patients, it’s worth exploring the difficulties of drug commissioning.